SMAD2 anticorps (pThr220)
Aperçu rapide pour SMAD2 anticorps (pThr220) (ABIN362418)
Antigène
Voir toutes SMAD2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- pThr220
-
Specificité
- The antibody detects endogenous level of Smad2 only when phosphorylated at threonine 220.
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography usingepitope-specific phosphopeptide. The antibody against non-phosphopeptide was removedby chromatography using non-phosphopeptide corresponding to the phosphorylation site.
-
Immunogène
- Peptide sequence around phosphorylation site of pThr220 (P-E-T (p) -P-P) derived from Human Smad2. Antibodies were produced by immunizing rabbits with synthetic phosphopeptide and KLH conjugates.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Western blotting: 1:500-1:1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
-
: "Induction of thoracic aortic remodeling by endothelial-specific deletion of microRNA-21 in mice." dans: PLoS ONE, Vol. 8, Issue 3, pp. e59002, (2013) (PubMed).
-
-
- SMAD2 (SMAD, Mothers Against DPP Homolog 2 (SMAD2))
-
Autre désignation
- Smad2
-
Sujet
- Transcriptional modulator activated by TGF-beta and activin type 1 receptor kinase. SMAD2 is a receptor-regulated SMAD (R-SMAD). May act as a tumor suppressor in colorectal carcinoma.
-
Poids moléculaire
- 60 kDa
-
UniProt
- Q15796
-
Pathways
- Cycle Cellulaire, Hormone Transport, Chromatin Binding, Protein targeting to Nucleus
Antigène
-